FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia
Excerpt from:
FDA Collaboration Seeks to Speed Development of Pneumococcal Vaccines for Children in Developing Countries
